Who we are?
Our History
Bionexx’s journey began in 2005 when artemisinin was selected by the WHO to treat malaria. The first phase of the project involved establishing the agricultural sector in Madagascar, followed by the acquisition of an extraction and purification site meeting international standards and the construction of a dedicated workshop for artemisinin production.
With a network of over 20,000 producers, Bionexx produces approximately 20 tons of artemisinin crystals annually, providing daily availability of artemisinin for 100,000 treatments (allowing 100,000 people to treat malaria daily). Bionexx is currently among the top 10 global artemisinin producers and the only one not located in China
In recent years, Bionexx has expanded its offer beyond artemisinin, enhancing Madagascar’s unique flora through a range of plant extracts.
- Sustainable Sourcing of Raw Materials
- High-Quality Extraction Processes
- Commitment to Innovation
- Strict Quality Control
- Regulatory Compliance
- Supply Chain Excellence
20 Years
of experience
Key Date
Acquisition of the industrial site, historically known as the Indena Madagascar site.
2013 : Production
After years of research, the first artemisinin crystals were obtained at a commercial scale.
2018 : Diversification
Diversification of the product range, highlighting the richness of the local flora.
What we done?
Key Date
- 2005 : Our BeginningBionexx was founded in 2005 with the aim to use artemisinin to treat malaria.
- 2008 : Our factoryAcquisition of the industrial site, historically known as the Indena Madagascar site.
- 2013 : ProductionAfter years of research, the first artemisinin crystals were obtained at a commercial scale.
- 2018 : DiversificationDiversification of the product range, highlighting the richness of the local flora.
What we do?
Our Numbers
Our Certifications
